← Back to Search

Skin Temperature Control During Simulated Blood Loss After Exercise Cold Stress for High Blood Pressure

N/A

Recruiting

Led By James Pearson, PhD

Research Sponsored by University of Colorado, Colorado Springs

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age between 18 and 40 years old

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up before and during lower body negative pressure (lbnp) procedure

Awards & highlights

Study Summary

This trial will look at how warming the skin during lower body negative pressure affects blood pressure and tolerance to blood loss after exercising in the cold.

Who is the study for?

This trial is for healthy adults aged 18-40 with normal blood pressure, who speak English and have no known diseases. Smokers, pregnant or breastfeeding individuals, those on certain medications, with physical limitations, a history of appendectomy or weighing less than 80 pounds cannot participate.Check my eligibility

What is being tested?

The study tests how skin warming affects blood pressure and tolerance to simulated blood loss after being in the cold and exercising. It involves rewarming the skin's surface using various methods while undergoing lower body negative pressure.See study design

What are the potential side effects?

Potential side effects may include discomfort from temperature changes during skin warming or cooling procedures and possible dizziness or lightheadedness due to simulated blood loss conditions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 40 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ before and during lower body negative pressure (lbnp) procedure

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~before and during lower body negative pressure (lbnp) procedure

This trial's timeline: 3 weeks for screening, Varies for treatment, and before and during lower body negative pressure (lbnp) procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Arterial blood pressure

Tolerance to simulated blood loss

Secondary outcome measures

Core temperature

Cutaneous Vascular Conductance

Trial Design

1Treatment groups

Experimental Treatment

Group I: Skin Temperature Control During Simulated Blood Loss After Exercise Cold StressExperimental Treatment4 Interventions

After exercise in the cold and participants skin will remain cold (~82°F), be returned to normal (~90°F), be slightly warmed (~93°F) or heated (~95°F) sixty seconds after the onset of LBNP.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Colorado, Colorado SpringsLead Sponsor

15 Previous Clinical Trials

4,755 Total Patients Enrolled

James Pearson, PhDPrincipal InvestigatorUniveristy of Colorado Colorado Springs

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who meets the criteria to participate in this medical study?

"To be considered for this research study, individuals must present with hypertension and fall between the ages of 18 and 40. The trial is limited to a total enrollment of 10 participants."

Answered by AI

Are there any available positions for participants in this research study?

"According to clinicaltrials.gov, this investigation is presently open for enrollment. The trial was first listed on 1/24/2022 and last revised on 2/22/2024."

Answered by AI

What is the current number of participants enrolled in this clinical research study?

"Yes, the details on clinicaltrials.gov indicate that this trial is presently in search of volunteers. The study was first listed on January 24th, 2022 and last revised on February 22nd, 2024. It aims to enroll a total of 10 participants from one designated site."

Answered by AI